|
|
|
| Therapeutic effect of central venous catheter closed thoracic drainage in the treatment of septal tuberculous pleurisy |
| LIAO Xin-hui LIU Xiao-ni ZHONG Bin ZHANG Gui-juan LIN Hai LAI Qing-wen▲ |
| Department of Respiratory Medicine,the First Affiliated Hospital of Gannan Medical College,Jiangxi Province,Ganzhou 341000,China |
|
|
|
|
Abstract Objective To investigate the clinical efficacy of central venous catheter closed thoracic drainage in the treatment of septal tuberculous pleurisy.Methods A total of 60 patients with septal tuberculous pleurisy admitted to our hospital from January to June 2019 were selected as the reaseach subjects.They were divided into the control group and the treatment group according to the order of admission,with 30 cases in each group.Both groups were treated with conventional anti-tuberculosis regimen.On this basis,the control group was treated with thoracentesis and the treatment group was treated with central venous catheter closed thoracic drainage.The clinical efficacy,disappearance time of effusion,length of hospital stay,incidence of adverse reactions and pleural thickening rate were compared between the two groups.Results The total effective rate of the treatment group (93.33%) was higher than that of the control group (73.33%),and the difference was statistically significant (P＜0.05).The disappearance time of effusion and length of hospital stay of the treatment group ([8.16±2.21]d,[9.33±2.34]d) were shorter than those of the control group([11.43±2.60]d,[13.28±2.85]d),and the differences were statistically significant (P＜0.05).During the treatment,the incidence of adverse reactions and pleural thickening rate in the treatment group (6.67%,6.67%) were lower than those in the control group (26.67%,30.00%),and the differences were statistically significant (P＜0.05).Conclusion Central venous catheter closed thoracic drainage is effective in the treatment of septal tuberculous pleurisy with fewer adverse reactions,can promote the disappearance time of effusion,prevent pleural thickening,and shorten the length hospital stay.
|
|
|
|
|
|
| [1] |
李阳.胸腔内注入尿激酶治疗结核性胸膜炎88例的临床疗效观察[J].当代医学，2017，23（8）：88-89.
|
| [2] |
Tian J，Xu L.Color Doppler Twinkling Artifact in Diagnosis of Tuberculous Pleuritis：A Comparison with Gray-Scale Ultrasonography and Computed Tomography[J].Ultrasound Med Biol，2018，44（6）：1291-1295.
|
| [3] |
金武，宋斌，卢水华，等.莫西沙星联合四联抗结核方案治疗结核性胸膜炎临床研究[J].中华医院感染学杂志，2019，29（14）：2090-2094.
|
| [4] |
厉娟，罗丹霖，张勇.胸腔闭式引流联合莫西沙星对结核性胸膜炎患者血清和胸腔积液炎性相关细胞因子的影响[J].湖南师范大学学报（医学版），2019，16（6）：37-41.
|
| [5] |
王瑜玲，秦焕，赵旭兰，等.内科胸腔镜联合不同方案对结核性包裹性胸腔积液的疗效影响[J].河北医药，2018，40（20）：3097-3100.
|
| [6] |
高静韬，王笑春，付亮，等.药物敏感性肺结核治疗和患者关怀指南——2017年更新版[J].国际呼吸杂志，2018，38（3）：161-168.
|
| [7] |
张艳丽，武丽，张贵贤，等.胸腔闭式引流治疗结核性胸膜炎的临床疗效[J].贵州医科大学学报，2018，43（9）：1105-1108，1113.
|
| [8] |
乔瑞君.丹红注射液配合胸腔闭式引流加四联抗结核药物治疗结核性胸腔积液的效果[J].中国医药导报，2018，15（20）：116-119.
|
| [9] |
林晔，李淳南，陈炀森.胸腔微创置管辅助尿激酶或链激酶注入治疗结核性胸膜炎临床评价[J].中国药业，2017，26（13）：39-41.
|
| [10] |
胡云衢，张凯，雷华君，等.中心静脉导管引流联合异烟肼及甲强龙胸腔内注射治疗结核渗出性胸膜炎的疗效[J].武警医学，2018，29（3）：301-303.
|
| [11] |
崔俊伟，王永亮，蔡瑞艳，等.中心静脉导管胸腔闭式引流联合超声引导靶位给药治疗结核性胸膜炎疗效观察[J].新乡医学院学报，2018，35（5）：400-403.
|
| [12] |
程冬明，任彩霞，郭光伟，等.两种不同引流方法治疗胸腔积液的疗效分析[J].中国药物与临床，2019，19（10）：1678-1680.
|
| [14] |
张建明，邓红丽，赵余，等.经中心静脉导管引流联合胸腔注射药物治疗结核性胸膜炎的临床观察[J].中国基层医药，2018，25（1）：76-79.
|
| [15] |
傅秀慧，赵磊，王瑜玲，等.内科胸腔镜联合尿激酶治疗结核性包裹性胸腔积液的疗效[J].河北医药，2018，40（4）：523-525，530.
|
| [16] |
任青青，汪娟.胸腔置管引流联合电视胸腔镜胸膜剥脱术治疗结核性包裹性胸膜炎[J].中国临床研究，2019，32（11）：1511-1514.
|
| [13] |
Petrella F，Maisonneuve P，Borri A，et al.Pleural catheters after thoracoscopic treatment of malignant pleural effusion：a randomized comparative study on quality of life[J].J Thorac Dis，2018，10（5）：2999-3004.
|
| [17] |
陈智德，莫旖旎，柯明耀，等.硅胶引流管与中心静脉导管在结核性胸膜炎胸腔镜检查术后的应用比较[J].临床肺科杂志，2017，22（2）：242-244.
|
| [18] |
孙卉，许红兰，刘晓玲.自制引流管贴膜在结核性胸膜炎置管护理中的应用观察[J].中国防痨杂志，2018，40（6）：649-651.
|
| [19] |
阳艳，游加宝.丹红注射液配合胸腔闭式引流加四联抗结核药物治疗结核性胸腔积液疗效观察[J].现代中西医结合杂志，2017，26（24）：2674-2676.
|
| [20] |
李磊.胸腔置管联合抗结核药治疗结核性胸膜炎患者胸腔积液的疗效分析[J].国际外科学杂志，2018，45（1）：25-28.
|
|
|
|
